Study unveils improved mRNA cancer vaccine targeting
Originally published by Chris Kocher, Binghamton University, in MedicalExpress on December 10, 2025
Edited
by Stephanie Baum, reviewed by Andrew Zinin
No matter
where cancer cells grow in the human body, they are a threat to our health and
our lives. But instead of treating them with chemotherapy or radiation—which
have undesirable side effects—what if we could train our own immune systems to
kill the rogue cells?
That's the
idea behind mRNA cancer vaccines, which build on science learned from COVID-19
vaccines to address an even larger health concern.
Writing
in Theranostics, Binghamton University Associate Professor Yuan Wan
and his collaborators outline a
better way to
target mRNA treatments. It builds on Wan's work over the past five years to
develop a better delivery method for chemotherapy medications.

Comments
Post a Comment